Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by BioTeckon Jan 18, 2021 1:53pm
238 Views
Post# 32321071

RE:RE:RE:Attn Sernova Dysfunctional Family

RE:RE:RE:Attn Sernova Dysfunctional FamilyIt looks like we have a fairly solid floor building above 1.85. US folks back from holiday will hopefully send a second  wave of buying. With the new 2.50 target and the other pieces in the works, this will be at 5 dollars in no time. Some of the items I hope and expect to hear from soon are:

Start of a clinical trial for Hemophilia now that we have warrant money. Pre-clinical results of the immuno tech. Pre-clinical thyroid data. Follow-up data on remaining patients. Deals/Collaborations with big pharma using the pouch for other indications not listed here.


I think management has to be careful with their deals now, we don't want to sign something that would prevent a full blown buyout. Hold on to your shares, this news release was only the start of things to come. 
<< Previous
Bullboard Posts
Next >>